Prevalence of Erythromycin Resistant emm92-type Invasive Group A Streptococcal Infections in West Virginia, United States, 2021-2023
L. M. Powell, S. J. Choi, B. L. Haught, R. Demkowicz, P. R. LaSala, S. Lukomski
This study identifies a high prevalence of erythromycin-resistant emm92-type invasive group A Streptococcus infections in West Virginia, linked to intravenous drug use.
bioRxiv · May 30, 2023 · PreprintMicrobiology